Considering that dysregulated CTPS levels and increased metabolic activity are characteristics of multiple forms of cancer (5, 10, –, 12, 41, 84, 85), and that both CTPS and TOR are often used as targets in anti-cancer drug development, a better understanding of how cells utilize and regulate CTPS becomes imperative. Here, CTPS1 is linked to cancer.